Previous close | 0.0700 |
Open | 0.0500 |
Bid | 0.0600 |
Ask | 0.1300 |
Strike | 80.00 |
Expiry date | 2022-12-16 |
Day's range | 0.0500 - 0.0800 |
Contract range | N/A |
Volume | |
Open interest | 120 |
mRNA blew open the door for more cold chain logistics business, helping UPS grow at twice the pace it had previously anticipated.
Pfizer (PFE) submits NDA to the FDA seeking approval for using its oral antiviral COVID pill in vaccinated and unvaccinated patients at a high risk of developing severe COVID-19 complications.
In anticipation of a new surge of COVID-19 infections later this year, the FDA recommends that COVID-19 vaccine manufacturers develop bivalent booster vaccines that contain the BA.4/BA.5 Omicron subvariants.